会议亮点 |
|
|
|
|
儿童风湿免疫性疾病研究热点 |
郑琪( ),卢美萍*( ) |
浙江大学医学院附属儿童医院风湿免疫过敏科, 浙江 杭州 310003 |
|
Focus on pediatric rheumatic and immune diseases |
ZHENG Qi( ),LU Meiping*( ) |
Department of Rheumatology, Immunology and Allergy, Children's Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China |
1 |
RAVELLI A , GROM A A , BEHRENS E M et al. Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis:diagnosis, genetics, pathophysiology and treatment[J]. Genes Immun, 2012, 13 (4): 289- 298
doi: 10.1038/gene.2012.3
|
2 |
MARTINON F , AKSENTIJEVICH I . New players driving inflammation in monogenic autoinflammatory diseases[J]. Nat Rev Rheumatol, 2015, 11 (1): 11- 20
doi: 10.1038/nrrheum.2014.158
|
3 |
KESSEL C , LIPPITZ K , WEINHAGE T et al. Proinflammatory cytokine environments can drive interleukin-17 overexpression by γ/δ T cells in systemic juvenile idiopathic arthritis[J]. Arthritis Rheumatol, 2017, 69 (7): 1480- 1494
doi: 10.1002/art.v69.7
|
4 |
崔咏望, 赵明奇, 李丰, 等. 可溶性受体CD163在难治性幼年特发性关节炎(全身型)中的意义及临床分析[J/CD]. 中华临床医师杂志: 电子版, 2013, 7(13): 5857-5860. CUI Yongwang, ZHAO Mingqi, LI Feng, et al. Significance and clinical analysis of soluble receptor CD163 in intractable systemic onset juvenile idiopathic arthritis[J/CD]. Chinese Journal of Clinicians: Electronic Edition, 2013, 7(13): 5857-5860. (in Chinese)
|
5 |
SCHULERT G S , CANNA S W . Convergent pathways of the hyperferritinemic syndromes[J]. Int Immunol, 2018, 30 (5): 195- 203
doi: 10.1093/intimm/dxy012
|
6 |
BEHRENS E M , BEUKELMAN T , PAESSLER M et al. Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis[J]. J Rheumatol, 2007, 34 (5): 1133- 1138
|
7 |
HENTER J I , HORNE A , ARICí M et al. HLH-2004:diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis[J]. Pediatr Blood Cancer, 2007, 48 (2): 124- 131
doi: 10.1002/(ISSN)1545-5017
|
8 |
RAVELLI A, MINOIA F, DAVì S, et al. Expert consensus on dynamics of laboratory tests for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis[J/OL]. RMD Open, 2016, 2(1): e000161.
|
9 |
RAVELLI A , MINOIA F , DAVìS et al. 2016 Classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis:a European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative[J]. Arthritis Rheumatol, 2016, 68 (3): 566- 576
doi: 10.1002/art.39332
|
10 |
噬血细胞综合征中国专家联盟中华医学会儿科学分会血液学组 . 噬血细胞综合征诊治中国专家共识[J]. 中华医学杂志, 2018, 98 (2): 91- 95 Chinese Expert Alliance on Hemophagocytic Syndrome, Hematology Group, Chinese Pediatric Society, Chinese Medical Association . Expert consensus on diagnosis and treatment of hemophagocytic syndrome[J]. National Medical Journal of China, 2018, 98 (2): 91- 95
|
11 |
YOKOTA S , ITOH Y , MORIO T et al. Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis under treatment with tocilizumab[J]. J Rheumatol, 2015, 42 (4): 712- 722
doi: 10.3899/jrheum.140288
|
12 |
MIETTUNEN P M , NARENDRAN A , JAYANTHAN A et al. Successful treatment of severe paediatric rheumatic disease-associated macrophage activation syndrome with interleukin-1 inhibition following conventional immunosuppressive therapy:case series with 12 patients[J]. Rheumatology(Oxford), 2011, 50 (2): 417- 419
doi: 10.1093/rheumatology/keq218
|
13 |
MOGHADDAS F , ZENG P , ZHANG Y et al. Autoinflammatory mutation in NLRC4 reveals a leucine-rich repeat (LRR)-LRR oligomerization interface[J]. J Allergy Clin Immunol, 2018,
|
14 |
GVNTHER C , BERNDT N , WOLF C et al. Familial chilblain lupus due to a novel mutation in the exonuclease Ⅲ domain of 3' repair exonuclease 1(TREX1)[J]. JAMA Dermatol, 2015, 151 (4): 426- 431
doi: 10.1001/jamadermatol.2014.3438
|
15 |
KIM H , SANCHEZ G A , GOLDBACH-MANSKY R . Insights from mendelian interferonopathies:comparison of CANDLE, SAVI with AGS, monogenic lupus[J]. J Mol Med(Berl), 2016, 94 (10): 1111- 1127
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|